Rupee plunges to record intraday, closing lows
“Demand from local importers continued to keep the rupee under pressure. There were some inflows, but they were all absorbed by the RBI. The central bank was seen protecting levels of 84.87 to 84.88 but RBI interventions did not change the direction of the pair,” said Anil Bhansali, head of treasury at Finrex Treasury Advisors.
Pharma, Capital Goods stocks new darlings of fund houses
India pharma companies’ progress in complex generics, stable US pricing and steady sales growth in India led to fund houses buying into stocks like Alembic Pharma, Divis Labs, Glenmark, Medplus, Orchid and Sanofi Consumer.